In November 2020, Oregon passed Measure 109, which has put into motion a program allowing – beginning in 2023 – the manufacture, delivery, and administration of psilocybin at supervised, licensed facilities within Oregon. This will be the first program of its kind anywhere in the United States, and perhaps the world.
“Green Light Law Group supports the legalization of psychedelics,” says partner Andrew DeWeese. “We believe Oregon is the optimum setting for the rollout of legal psychedelics in the United States. The program offers the potential for patients in Oregon to access a possibly revolutionary mental health treatment in a legal, supervised setting.”
The first feature of Measure 109 is its two-year development period, which began on January 1, 2021, and will end on December 31, 2022. This development period allows time for state legislators and regulatory agencies to design a therapeutic psychedelics program.
Green Light Law Group works with clients in the emerging legal psychedelics field to update and advise them on the status of the development period and provide insights into the evolving legal psychedelics business ecosystem in Oregon.
We provide the following legal services of particular interest to entrants and participants in the psychedelics space:
- Corporate finance and securities
- Entity formation and corporate governance
- Technology and ecommerce agreements
- Clinic management agreements
- Employment and practitioner contracts
- Real estate and leasing agreements
- Licensing and regulatory advice
- Administrative litigation and appeals